Fesoterodine Fumarate 相關新聞

← 返回新聞總覽


Fesoterodine Fumarate 目前有 0 則相關新聞報導,預測適應症 20 個。

本頁整合 Fesoterodine Fumarate 的 AI 預測適應症與最新健康新聞,橘色標示的適應症表示近期有相關新聞報導。
藥物資訊
  • 原適應症:Treatment of the symptoms (increased urinary frequency and / or urgency and / or urgency incontinence) that may occur in patients with overactive-bladder syndrome.
  • 證據等級:L5
  • 預測適應症(20 個):
    • overactive bladder (disease)(98.9%)
    • polycystic kidney disease 3 with or without polycystic liver disease(91.1%)
    • thoracic malformation(89.9%)
    • renal-hepatic-pancreatic dysplasia(89.6%)
    • Joubert syndrome with renal defect(88.5%)
    • adult familial nephronophthisis-spastic quadriparesia syndrome(88.4%)
    • karyomegalic interstitial nephritis(87.3%)
    • low compliance bladder(86.5%)
    • faciodigitogenital syndrome(84.8%)
    • attention deficit-hyperactivity disorder(82.4%)
    • polycystic kidney disease(79.9%)
    • congenital analbuminemia(74.6%)
    • hyperamylasemia(72.9%)
    • polyclonal hyperviscosity syndrome(72.9%)
    • restless legs syndrome(67.5%)
    • communication disorder(67.0%)
    • tic disorder(66.2%)
    • developmental disorder of mental health(65.8%)
    • stereotypic movement disorder(65.0%)
    • fetal nicotine spectrum disorder(65.0%)

查看完整藥物報告 →

相關新聞(0 則)

目前沒有相關新聞報導。當有新聞提到此藥物時,系統會自動收集並顯示在這裡。

免責聲明:本頁新聞由系統自動收集,僅供研究參考,不構成醫療建議。

Copyright © 2026 EuTxGNN Project. For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.